Rockefeller Capital Management’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
Other funds holding UNCY
Rockefeller Capital Management's UNCY Position: Q3 2026 in Review
Rockefeller Capital Management increased its Unicycive Therapeutics (UNCY) stake by 429% in Q3 2026, buying an estimated $46.6K and bringing the position to 11,100 shares worth $52.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3438.
Rockefeller Capital Management first reported a position in UNCY in Q3 2025 and has held it in 5 quarters since. 91 funds tracked by Wall St. Rank hold UNCY as of Q3 2026.
- Rockefeller Capital Management held 11,100 shares of Unicycive Therapeutics worth $52.1K as of Q3 2026.
- Rockefeller Capital Management bought 9,000 Unicycive Therapeutics shares in Q3 2026, an estimated $46.6K.
- Unicycive Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #3438 holding.
- Rockefeller Capital Management first reported a position in Unicycive Therapeutics in Q3 2025 and has held it in 5 quarters since.
- 91 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.